Works matching IS 11707690 AND DT 2017 AND VI 35 AND IP 12
Results: 9
Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal Practice.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Treatments for Metastatic Prostate Cancer (mPC): A Review of Costing Evidence.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Economic Considerations in the Use of Novel Targeted Therapies for Lung Cancer: Review of Current Literature.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Economic Evaluation of Implementing a Novel Pharmacogenomic Test (IDgenetix<sup>®</sup>) to Guide Treatment of Patients with Depression and/or Anxiety.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Acknowledgement to Referees.
- Published in:
- 2017
- Publication type:
- journal article
Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2017
- By:
- Publication type:
- journal article